Although STAT1 is classically associated with tumor-suppressive interferon responses, mounting evidence suggests that in TNBC, STAT1 can acquire pro-tumorigenic functions, promoting stemness, proliferation, inflammatory cytokine production, and poor clinical outcomes [24,30]. This evidence concerns the gene STAT1 and neoplasm.